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Current paradigm equates an organism’s genome with its complete DNA sequence. However, 
results from omics research show that the genome is more than the DNA sequence. For 
example, sequence alone does not determine multi-functionality of regulatory elements (e.g. 
enhancers, insulators). In addition, identity of genomic elements depends on cellular and 
temporal context. Based on these findings, the present work advances the hypothesis that the 
genome is an emergent entity resulting from epigenomics mechanisms. The genome can be 
understood as the mapping of identity-functions to elements along the DNA molecule. The 
mapping can vary across cellular types and developmental times. As consequence, the same 
organism can have multiple genomes regardless of the underlying DNA sequence. The 
proposed theory has major implications for the study of the hereditary basis of phenotypic traits, 

















“From now onwards space by itself and time by itself will recede completely to become mere 
shadows and only a type of union of the two will still stand independently on its own.” 
Hermann Minkowski, lecture at the 80th Meeting of German Natural Scientists, Cologne, 
September 21, 1908 
 
INTRODUCTION 
Current theory and practice in genetics treat the genome and epigenome as two related 
although different entities. For example, the epigenome is usually defined as “… a multitude of 
chemical compounds that can tell the genome what to do” (National Human Genome Research 
Institute, https://www.genome.gov/27532724/epigenomicss-fact-sheet/), the genome being “… 
an organism’s complete set of DNA, including all of its genes” (U.S. National Library of 
Medicine, https://ghr.nlm.nih.gov/primer/hgp/genome). Popular metaphors compare the 
epigenome to an electrical switch turning on and off a light bulb (see for example 
https://www.mpg.de/9910690/epigenetic-switch-obesity), or to annotations on a music score to 
change musical performance (see for example Epigenome: The symphony in your cells, 
http://www.nature.com/news/epigenome-the-symphony-in-your-cells-1.16955; and (Burris and 
Baccarelli, 2014)). Implicit on these definitions and metaphors is the ontological priority of the 
genome over the epigenome. Before any regulation could take place, there must be genes to be 
regulated. Before we turn on or turn off a light bulb, there must be a light bulb. Before we 
annotate a music score, there must be a music score. In other words, according to these 
definitions and metaphors, we could have a genome without an epigenome but not an 
epigenome without a genome. However, as I will discuss below, the current paradigm has both 
theoretical and practical limitations. I will argue that 1) neither the epigenome nor the genome 
can exist independently from each other, 2) the genome is an emergent entity resulting from 
epigenomics mechanisms, and 3) the epigenome and genome are part of a larger entity; the 
EpG2 (EpiGenome-Genome) system. 
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THE GENOME DOES NOT EXIST WITHOUT THE EPIGENOME 
In day-to-day talk is common use to identify the genome as the complete DNA sequence of an 
organism. For example, the international project that determined the complete sequence of the 
human DNA was known as the Human Genome Project (HGP), and terms such as “whole-
genome sequencing” (WGS) are used to refer to experiments that sequence the totality of an 
organism’s DNA. However, if we accept that an organism’s genome is composed all of its 
genes, as well as regulatory (e.g. enhancers, insulators, promoters), structural (e.g. loop 
anchors, topologically associating domain (TAD) boundaries), and others still unknown 
functional elements then, as I will argue with some examples below, the genome is more than 
the DNA sequence. I will propose that the genome is an emergent entity, which results from 
epigenomics mechanisms. 
 
What is a gene? 
“What then is time? If no one asks me, I know what it is. If I wish to explain it to him who asks, I 
do not know.” (Augustine, Confessions, Book XI, Chapter 14) 
 
Modern biologists have a similar problem as Augustine’s. We talk about genes in our daily 
professional practice. However, if we are pressed to define and explain what a gene is, we run 
into difficulties sooner rather than later. As discussed in details by others (Carlson, 1991; 
Gerstein et al., 2007; Griffiths and Stotz, 2006; Pesole, 2008; Portin and Wilkins, 2017; Scherrer 
and Jost, 2007), classical definitions of the “gene” concept fail to capture the complexity 
revealed by results from current research. Nested and overlapping genes, alternative and trans 
RNA splicing, extensive and continuous transcription along the DNA molecule are just a few 
examples of the phenomena that challenge our traditional understanding of the gene. I will not 
propose a new definition of the “gene” in this work, as many other authors have advanced novel 
ideas in how to redefine the “gene” in light of our current knowledge (Carlson, 1991; Gerstein et 
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al., 2007; Griffiths and Stotz, 2006; Pesole, 2008; Portin and Wilkins, 2017; Scherrer and Jost, 
2007). What these new definitions have in common is 1) the DNA sequence does not 
completely determine what a gene is or even where a particular gene is located in the genome, 
and 2) functional products (e.g. non-coding RNAs, proteins) are necessary for gene identity and 
location. In other words, the gene is in some sense a multidimensional and emergent entity 
involving material substrates (DNA, RNA, and protein) as well as the processes connecting 
them.  
 
Promoter or enhancer?  Insulator or promoter? Enhancer or insulator? What is it out 
there? 
Identity (what it is) of regulatory and structural elements in the genome is tightly linked to their 
function (what it does). We say, for example, that promoters are proximal DNA sequences 
upstream of a gene that specify transcription start; enhancers are distal elements that increases 
transcription of genes; silencers suppress gene expression, and so forth (Maston et al., 2006). 
Recent results show that genomic elements are rather multifunctional: enhancers may act as 
silencers and vice versa (Kolovos et al., 2012), promoters and enhancers have exchangeable 
functions (Andersson, 2015; Kim and Shiekhattar, 2015), insulators may behave as promoters 
(Wei and Brennan, 2001), and tRNA genes may serve as insulators as well (Raab et al., 2012; 
Van Bortle and Corces, 2012). As I discuss below, these observations have unappreciated 
implications for our understanding of what is the genome. 
 
Let us say there is a genomic element that have both enhancer and promoter activities, does 
this mean the element is 1) a promoter with added enhancer activity, 2) an enhancer with added 
promoter activity, or 3) both an enhancer and promoter with their corresponding activities. 
Implicit on these three alternatives is an absolute notion of genome, which stems from the 
traditional view of equating an individual’s genome with its complete DNA sequence. According 
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to this thinking, a person’s genome is a fixed entity that, excepting somatic mutations and 
rearrangements, does not varies over time or cell type. This is the meaning of the usual 
expression saying that all cells of an individual have the same genome. However, if the genome 
is the set of all genes, regulatory and boundary elements, and any new functional elements yet 
to be discovered it is clear, from available evidence, that the genome is not the same as the 
complete DNA sequence. First, sequence alone does not determine identity or function of 
genomic elements. Instead, identify-function of genomic elements depends on the underlying 
DNA sequence, DNA-bound proteins (e.g. transcription factors, CTCF, etc.), cellular context, 
and developmental stage (Andersson, 2015; Erceg et al., 2017; Fourel et al., 2004; Palstra and 
Grosveld, 2012). Second, from an evolutionary point of view, DNA sequence conservation does 
not completely correlate with identity-function of genomic elements. In vertebrates, numerous 
enhancers have conserved function but divergent sequences (Yang et al., 2015), and new 
genomic elements may emerge without change of the underlying DNA sequence (i.e. exaptation 
of ancestral DNA) (Domene et al., 2013; Rebeiz and Tsiantis, 2017; Villar et al., 2015). At last, 
formation of new enhancers may result from the overexpression of transcription factors without 
changes in the DNA sequence (Hnisz et al., 2013; Shin, 2018). Although, this phenomena has 
been observed for now only in conditions such as cancer (Hnisz et al., 2013; Shin, 2018), it 
opens the possibility that in normal situations, genomic elements may emerge depending on 
concentrations and combinations of transcription factors, other DNA-bound proteins, and 
cellular context. In summary, 1) the genome is not a fixed entity corresponding to the complete 
DNA sequence of an organism, instead 2) the genome emerges as part of a new dynamic entity 







THEORY OF THE EpG2 SYSTEM 
The following requires a basic knowledge of set and topology theory. However, main 
conclusions will be presented in an intuitive way. Consider the whole DNA molecule(s) of an 
individual composed of m genetic (i.e. sequence) elements. We will define: 
 
Definition 1 
• G is the set of n genetic elements in the whole DNA of an organism. 
• G = {g1, g2, …, gn}, where gi is the i-th genetic element 
 
Definition 2 
• (G, ) is the genetic space with discrete topology, which means every possible subset of G –
including the empty set  and G itself are open sets– is open. For example, let us assume a 
genetic set G with only three elements: G = {g1, g2, g3}. Then, the topological space (G, ) 
will include all possible subsets of G: (G, ) = {, {g1}, {g2}, {g2}, {g1, g2}, {g1, g3}, {g2, g3}, {g1, 
g2, g3}}. 
• We will use the notation Gij…k to represent the {gi, gj, …, gk} open set.  According to this 
notation, the above topological space (G, ) can be written as (G, ) = {, G1, G2, G3, G12, 
G13, G23, G123}. 
 
Definition 3 
• F is the set of biologic identity-functions of an organism. 







• 𝜋: 𝐹 → (𝐺, 𝜏) is an injective mapping from the F set to the topological space (G, ) that is, if 
two identify-functions fa and fb map to the same open set Gij…k then fa and fb are the same 
identity-function. In other words, for a given  mapping two different identity-functions cannot 
map to the same open set. Symbolically, fa, fb  F, (fa) = (fb)  fa = fb.  
• For example, suppose the G set has three genetic elements, and the F set has three 




























Figure 1. An example of  mapping of the set F of identity-functions to the genetic topological 





The mapping shown in Figure 1 can be represented as an m x n matrix H, where m (number of 
rows) equals the number of identity-functions, and n (number of columns) equals the number of 
genetic elements. The matrix element hij is equal to one if the j-th genetic element is included in 
the open set that is the image of the i-th identity-function, and equal to zero otherwise. 
Symbolically, 
hij = 1 if gj  (fi) 
hij = 0 if gj  (fi). 
The above  mapping can be represented by the matrix 
𝑭
𝝅





where the i-th row vector 𝒓𝒊 denotes the open set (fi). From the above H matrix, the first 
identity-function (first row-vector) maps to the open set composed of the second genetic 
element, the second identity-function (second row-vector) maps to the open set composed of 
the first and second genetic elements, and the third identity-function (third row-vector) maps to 
the open set composed of the second and third genetic elements. 
 
Multiple  mappings  
The  mapping represented in Figure 1 and matrix H is just one of the possible mappings from 
the set F to the topological space (G, ). In general, given a F set with m identify-functions, and 
a genetic set with n genetic elements, standard set theory shows that the topological space (G, 
) has 2n open sets resulting in 
2𝑛!
(2𝑛−𝑚)!
 possible injective  mappings from F to (G, ). Although it 
is possible that many, if not most, of these potential mappings do not exist due to negative 
natural selection, there is still a big reservoir of mappings available to the organism. We will use 
the notation 𝑭
𝝅𝒋
→ (𝑮, 𝝉), where j is the j-th mapping from F to (G, ), to represent different 
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mappings. Each j mapping can be represented by an m x n Hj matrix as described above. The 
row-vector 𝒓𝒊
𝒋
 denotes the open set 𝜋𝑗(𝑓𝑖) that is, the set of genetic elements mapped by the i-th 
identity-function in the j mapping. We will call  as the set of possible mappings of an 
organism:  = {1, 2, …,p}. 
 
Similarity between  mappings 
Let us to define and calculate a similarity metric – or its opposite, a distance metric – between 
mappings. We will define the similarity S between mappings 𝜋𝑖 and 𝜋𝑗 as the average similarity 
between open sets 𝜋𝑖(𝑓𝑘) and 𝜋𝑗(𝑓𝑘), k = 1, 2, …, m where m equals the number of identity-
functions. Similarity between open sets 𝜋𝑖(𝑓𝑘) and 𝜋𝑗(𝑓𝑘) is the number of shared genetic 

















;           0 ≤ 𝑆(𝜋𝑖, 𝜋𝑗) ≤ 1 
 
A distance metric between mappings 𝜋𝑖 and 𝜋𝑗 can be defined as 
𝐷(𝜋𝑖, 𝜋𝑗) = 1 − 𝑆(𝜋𝑖, 𝜋𝑗);                        0 ≤ 𝐷(𝜋𝑖, 𝜋𝑗) ≤ 1 
  
As example, three different mappings, with three identity-functions and three genetic elements, 
are shown below 
𝑭
𝝅𝟏




) ;    𝜋1(𝑓1) = 𝐺1,     𝜋1(𝑓2) = 𝐺2,     𝜋1(𝑓3) = 𝐺3 
𝑭
𝝅𝟐













) ;    𝜋3(𝑓1) = 𝐺12,     𝜋3(𝑓2) = 𝐺13,     𝜋3(𝑓3) = 𝐺23 



















































The EpG2 system as a fiber bundle 
Individuals consist of different cell types that develop over time. Let us define C as the set of all 
cell types of an organism, T as the set of all developmental times, and S as the Cartesian 
product of C and T, 𝑆 = 𝐶 × 𝑇. We will show that the set  (i.e. the set of possible  mappings) 
generates a partition of S. For simplicity –without lack of generality– let us assume four different 
cell types, C = {c1, c2, c3, c4}; four different developmental times, T = {t1, t2, t3, t4}; and four 
different  mappings,  = {1, 2, 3, 4}. Figure 2 shows an example of the space S and its 





(c1, t4) (c2, t4) (c3, t4) (c4, t4) 
(c1, t3) (c2, t3) (c3, t3) (c4, t3) 
(c1, t2) (c2, t2) (c3, t2) (c4, t2) 
(c1, t1) (c2, t1) (c3, t1) (c4, t1) 
FIGURE 2 Figure 2. Space S = C x T of four cell types and four 
developmental times. The coordinate pair (ci, tj) denotes 
the i-th cell type in the j-th developmental time. Each 
color represents a different  mapping: 1 (red), 2 
(blue), 3 (green), and 4 (orange). Coordinate pairs 
under the same color form an equivalence class; they 







The coordinate pair (ci, tj) represents the i-th cell type in the j-th developmental time. Two 
coordinate pairs are equivalent, (ci, tj) ~ (ck, tl), if they use the same  mapping. In the example 
shown in Figure 2, the equivalence relation generates four equivalence class. The set of 
equivalence classes generated by the equivalence relation ~ is called the quotient set of S by ~ 
and is denoted by S/~. In the present example, 
 
S/~ = {1, 2, 3, 4}, where 
1 = {(c1, t1), (c1, t2), (c1, t3), (c1, t4)} 
2 = {(c2, t3), (c2, t4), (c3, t3), (c3, t4), (c4, t3), (c4, t4)} 
3 = {(c2, t1), (c2, t2)} 
4 = {(c3, t1), (c3, t2), (c4, t1), (c4, t2)} 
 
The quotient map  is the surjective function that sends each member of S to its respective 






The set  of  mappings and the quotient set S/~ of equivalence classes are isomorphic to each 
other, as there is a one-to-one correspondence between  mappings and  equivalence classes 
(see Figure 2). Symbolically 
 
𝚷 =̃ 𝑺/~ 
 
Because of the isomorphism between  and S/~ we can also say that the quotient function  







We are ready now to define the EpG2 system from a set theory perspective. The EpG2 system is 
a structure constituted of the space S and the space . As Figure 2 shows, the different  
mappings generate a partition of the space S. Using standard topology terminology, we say that 
the EpG2 system is a fiber bundle with base space S and fiber . In particular, the EpG2 system 
may be thought as composed of a group of fibers (i.e.  mappings) “above” the base space S. 
Each particular fiber maps to an open set in the base space S.  
 
Genetic basis of complex diseases 
Ongoing research tries to find the genetic basis (i.e. DNA sequence variation) of complex 
human diseases. Some points should be considered based on the hypothesis proposed in the 
current work: 
1) To map a complex phenotypic trait to DNA elements (i.e. the genetic space (G, )), we 
first need a map from the set of phenotypic traits (P) to the set of biological identity-
functions (F). 
2) A complex phenotypic trait is a global time-dependent property of the individual. This 
means, an emergent property of the whole individual. 
3) Because of points 1) and 2), the mapping from phenotypic traits to biological identity-
functions, and therefore to DNA elements, will vary by developmental time and cell type. 
 







• P is the set of q phenotypic traits of the organism 
• P = {p1, p2, …, pq}, where pi is the i-th phenotypic trait 
 
Definition 6 
• (F, ) is the biological identity-function space with discrete topology, which means every 
possible subset of F –including the empty set  and F itself are open sets– is open. For 
example, let us assume a biological identity-function with three elements: F = {f1, f2, f3}. 
Then, the topological space (F, ) will include all possible subsets of F: (F, ) = {, {f1}, {f2}, 
{f2}, {f1, f2}, {f1, f3}, {f2, f3}, {f1, f2, f3}}. 
• We will use the notation Fij…k to represent the {fi, fj, …, fk} open set.  According to this 




• 𝜎: 𝑃 → (𝐹, 𝜏) is an injective mapping from the P set to the topological space (F, ) that is, if 
two phenotypic traits pa and pb map to the same open set Fij…k then pa and pb are the same 
phenotypic trait. In other words, for a given  mapping two different phenotypic traits cannot 
map to the same open set. Symbolically, pa, pb  P, (pa) = (pb)  pa = pb.  
• Assuming a P set with two phenotypic traits and a F set with three identity function, Figure 3 
shows an example of  mapping from the P set to the (F, )  identity-function space.  
• The  mapping shown in Figure 3 is just one of multiple mappings that will vary by cell type 
and developmental time. In general, 𝜎𝑖𝑗: 𝑃 → (𝐹, 𝜏) will be the  mapping in the i-th cell type 





















• The 𝛾: 𝑃 → (𝐺, 𝜏) mapping from the P set to the genetic topological space (G, ) is the 
combination of the 𝜋: 𝐹 → (𝐺, 𝜏) and 𝜎: 𝑃 → (𝐹, 𝜏) mappings as follows 
 


































Figure 3. An example of  mapping of the set P of phenotypic traits to the topological space 




• For example, combining the  mapping from Figure 1: (f1) = G2, (f2) = G12, and (f3) = G23; 
with  mapping from Figure 3: (p1) = F1, and (p2) = F23, we get the corresponding  
mapping: (p1) = G2, and (p2) = G123. 
• The  mapping will vary over cell type and developmental time. In general,  




• A phenotypic trait including diseases are global properties of the organism. This means, a 
particular phenotypic trait PA at time T, which we will call 𝑃𝐴
𝑇, depends on the life history of 




𝑇𝑝𝑎𝑖𝑗 will be the particular phenotypic trait PA at time T. The I operator represents a 
biological integration over cell type and developmental time. In particular: 
𝐼𝑖
𝐶 = biological integration over all C cell types (i = 1, 2, …, C), 
𝐼𝑗
𝑇= biological integration up to time T (j = 1, 2, …, T), 
𝑝𝑎𝑖𝑗= contribution of the i-th cell type at the j-th developmental time to the phenotypic trait 
PA. In other words, 𝑝𝑎𝑖𝑗 is the set of identity-functions in the i-th cell type at the j-th 
developmental time that contributes to the global phenotypic trait PA.  
 
DISCUSSION AND IMPLICATIONS 
The genome and epigenome do not exist independent from each other 
A major claim of the present work is that the genome and the epigenome do not have 
independent existence from each other. Present-day paradigm assigns ontological primacy to 
the genome over the epigenome, that is, the former exists –in an ontological sense– before the 
latter. For example, a survey of textbooks, scientific articles, websites, etc. shows that the 
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genome is defined without any reference to the epigenome, which at the same time is defined 
always in reference to the genome. Current thinking is based on the identification of an 
organism’s genome with the whole of its DNA, and the epigenome with the complete set of 
chemical changes on the DNA itself (e.g. cytosine methylation) or associated proteins (e.g. 
histone modifications) regulating genome’s activity. However, as I argue in the present work, the 
genome and the epigenome are different aspects of the same EpG2 system. The  mapping 
illuminates these two aspects. For example, we could define an organism’s genome as the 
image (i.e. range) of the  mapping that is, the set of DNA elements that are the output of the  
mapping. However, we should notice that a DNA element gA becomes a genomic element  
only after being paired with their respective identity-function fA. In other words, it is the ordered 
pair (fA, gA) that is a genomic element rather than the DNA element gA alone. Therefore, we can 
define the genome as the set of all ordered pairs (f, g) for a particular  mapping; which for 
definition, based on standard set theory, is the  mapping itself. We should also note that 
because the same individual organism has several different  mappings (i.e. fibers of the EpG2 
system) then, it would have several different genomes too. This multiplicity of genomes in the 
same individual should not be confused with somatic differences of DNA sequence across 
tissues (Yizhak et al., 2019). Rather, the present work proposes that DNA sequence is not 
synonymous of genome, and different genomes can have the same underlying DNA sequence. 
 
On the other hand, how can we define the epigenome? Based on current definitions, the 
epigenome consists of chemical changes to the DNA molecule (e.g. cytosine methylation) and 
associated proteins (e.g. histone modifications) that regulate genome’s activity (e.g. gene 
expression). I postulate that the epigenome, more than just telling the genome what do, defines 
what the genome is. Then, we can define the epigenome as the set of mechanisms leading to 
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the emergence of a particular  mapping (i.e. genome) in a particular cell type and 
developmental time.  
 
It is clear from the above discussion that the genome has no independent existence from the 
mechanisms (i.e. epigenome) resulting on its emergence. In addition, because a mechanism 
can be understood as a process occurring in a particular system (Bunge, 1997) then then the 
epigenome exists a part of a system: the EpG2 system.     
 
A multilevel epigenome 
Our definition of the epigenome as the mechanisms responsible for the emergence of the 
genome can be expanded to include regulatory mechanisms of genome’s activity. The 
epigenome will be then a series of multi-level mechanisms responsible for the emergence of the 
genome and the regulation of the genome’s activity (Figure 4). The first, high-level epigenome 
will control the assignment of function-identity to the different DNA elements. This mapping of 
function-identity all throughout the DNA molecule will result on the emergence of the genome. 
Once again, the present work advances the hypothesis that this mapping can vary by 
development time and cell type (i.e. same DNA elements may have different function-identity 
across the S space, see Figure 2). Therefore, the genome is not an absolute entity but rather 
an emergent one. The second, low-level epigenome will regulate the activity of the emerged 
genome. For example, levels of gene expression, use of alternative promoters, etc. 
Unfortunately, because present day paradigm assigns ontological primacy to the genome over 
the epigenome most, if not all, of ongoing research focuses on the lower level of the epigenome, 
and there is a complete lack of studies about high-level epigenomics mechanisms leading to the 



























A robust, research program must take into account the multi-level epigenome and the emergent 




































Figure 4. The multi-level epigenome and the emergent genome. The first, high-level epigenome 
consists of a series of mechanisms resulting on the emergence of the genome. The second, low-
level epigenome is responsible for the regulation of genome’s activity. The multi-level epigenome 




1. Epigenomics mechanisms leading to the emergence of the genome. Because current 
paradigm considers the genome as an absolute entity, whose existence does not depend on 
epigenomics processes, this question is not even asked. A robust research program should 
identify high-level epigenomics mechanisms responsible for the emergence of the genome 
throughout different cell types and developmental times. 
2. Individual variation of the multi-level epigenome. To date, it is widely recognized the 
existence of person-to-person variation on low-level epigenomics mechanisms (e.g. DNA 
methylation) that may result on differences of genome’s activity (e.g. levels of gene 
expression). Our proposed theory posits the existence of a high-level epigenome, which is 
responsible for genome emergence (Figure 4). Future research should address several 
questions: 
a. Is there inter-individual variation in the first, high-level epigenome as well (i.e. 
person-to-person variation in the  mappings)?  
b. Factors affecting variation of the multi-level epigenome. 
c. Relationship between variation of the multi-level epigenome and phenotypic traits 
including disease. 
3. Genomic variation and disease. An active field of research is the elucidation of the 
hereditary basis of disease. What this means in practice is the assessment of how DNA 
sequence variation affects both risk and severity of disease. However, as proposed in the 
current work, an organism can be viewed as a bundle of different genomes (i.e.  mappings) 
that vary by cell types and developmental times. In must be noted again, that these different 
genomes may have the same underlying DNA sequence, as they refer to different  
mappings. As consequence, same physical positions along the DNA molecule may have 
different identity-function depending on the respective genome (i.e.  mapping). In addition, 
if there is person-to-person variation of the  mappings (see point 2 above) inter-individual 
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variation in the DNA sequence is not equivalent to inter-individual genomic variation. 
Standard approaches such as genome-wide association studies and whole-genome 
sequencing association studies would fail to elucidate how genome variation affects 
disease, as they focus on variation of the underlying DNA sequence that is not necessarily 
the same as genomic variation. A new approach should consider genomic variation across 
cell types and developmental times as the effect of DNA sequence variation on disease 
cannot be disentangled from the subject’s life-story as genomes (see genetic basis of 
complex diseases section).  
 
SUMMARY 
In the present work, I argue that even though the DNA is part of the material basis of the 
genome, the latter is more than the DNA sequence. The genome is rather an emergent entity 
resulting from epigenomics mechanisms. The proposed hypothesis has important implications 
for the study of the epigenomics and genomic basis of phenotypic traits, including diseases, and 
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